Exact Therapeutics AS (OSL:EXTX) Other Current Receivables : kr8.31 Mil (As of Dec. 2023)

View and export this data going back to 2020. Start your Free Trial

What is Exact Therapeutics AS Other Current Receivables?

Exact Therapeutics AS's Other Current Receivables for the quarter that ended in Dec. 2023 was kr8.31 Mil.

Exact Therapeutics AS's quarterly Other Current Receivables increased from Dec. 2022 (kr7.88 Mil) to Jun. 2023 (kr9.17 Mil) but then stayed the same from Jun. 2023 (kr9.17 Mil) to Dec. 2023 (kr8.31 Mil).

Exact Therapeutics AS's annual Other Current Receivables increased from Dec. 2021 (kr7.16 Mil) to Dec. 2022 (kr7.88 Mil) and increased from Dec. 2022 (kr7.88 Mil) to Dec. 2023 (kr8.31 Mil).

Exact Therapeutics AS Other Current Receivables Historical Data

The historical data trend for Exact Therapeutics AS's Other Current Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Exact Therapeutics AS Other Current Receivables Chart

Exact Therapeutics AS Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Other Current Receivables

Get a 7-Day Free Trial

4.71

5.23

7.16

7.88

8.31

Exact Therapeutics AS Semi-Annual Data
	Dec17	Dec18	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Other Current Receivables	Get a 7-Day Free Trial						7.16	8.54	7.88	9.17	8.31

Exact Therapeutics AS Other Current Receivables Calculation

GuruFocus uses a standardized financial statement format for all companies. GuruFocus lists Accounts Receivable, Notes Receivable , Loans Receivable and Other Current Receivables under the "Total Receivables" section.

Exact Therapeutics AS Other Current Receivables Related Terms

Thank you for viewing the detailed overview of Exact Therapeutics AS's Other Current Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

Exact Therapeutics AS (OSL:EXTX) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Exact Therapeutics AS (OSL:EXTX) » Definitions » Other Current Receivables

Comparable Companies

Traded in Other Exchanges

N/A

Address

Ostre Aker vei 19, Oslo, NOR, 0581

Website

https://www.exact-tx.com

Exact Therapeutics AS is a clinical-stage biotechnology company. It is developing a technology platform for therapeutic enhancement - Acoustic Cluster Therapy (ACT). ACT sonoporation is an approach to ultrasound-mediated, targeted drug enhancement that will amplify the clinical utility of therapeutic agents across a multitude of indications including within oncology (chemotherapy, immunotherapy), infectious diseases, and neurological conditions.

Exact Therapeutics AS (OSL:EXTX) Headlines

No Headlines